Cargando…

The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?

Detalles Bibliográficos
Autores principales: Peng, Ye, Zhao, Jincun, Tun, Hein M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456457/
https://www.ncbi.nlm.nih.gov/pubmed/32877709
http://dx.doi.org/10.1053/j.gastro.2020.08.048
_version_ 1783575803108261888
author Peng, Ye
Zhao, Jincun
Tun, Hein M.
author_facet Peng, Ye
Zhao, Jincun
Tun, Hein M.
author_sort Peng, Ye
collection PubMed
description
format Online
Article
Text
id pubmed-7456457
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-74564572020-08-31 The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients? Peng, Ye Zhao, Jincun Tun, Hein M. Gastroenterology Correspondence by the AGA Institute 2021-05 2020-08-30 /pmc/articles/PMC7456457/ /pubmed/32877709 http://dx.doi.org/10.1053/j.gastro.2020.08.048 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Peng, Ye
Zhao, Jincun
Tun, Hein M.
The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?
title The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?
title_full The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?
title_fullStr The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?
title_full_unstemmed The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?
title_short The New Foe and Old Friends: Are We Ready for Microbiota-Based Therapeutics in Treating COVID-19 Patients?
title_sort new foe and old friends: are we ready for microbiota-based therapeutics in treating covid-19 patients?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456457/
https://www.ncbi.nlm.nih.gov/pubmed/32877709
http://dx.doi.org/10.1053/j.gastro.2020.08.048
work_keys_str_mv AT pengye thenewfoeandoldfriendsarewereadyformicrobiotabasedtherapeuticsintreatingcovid19patients
AT zhaojincun thenewfoeandoldfriendsarewereadyformicrobiotabasedtherapeuticsintreatingcovid19patients
AT tunheinm thenewfoeandoldfriendsarewereadyformicrobiotabasedtherapeuticsintreatingcovid19patients
AT pengye newfoeandoldfriendsarewereadyformicrobiotabasedtherapeuticsintreatingcovid19patients
AT zhaojincun newfoeandoldfriendsarewereadyformicrobiotabasedtherapeuticsintreatingcovid19patients
AT tunheinm newfoeandoldfriendsarewereadyformicrobiotabasedtherapeuticsintreatingcovid19patients